Sowell Financial Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $201K | Buy |
+616
| New | +$201K | 0.01% | 972 |
|
|
2021
Q2 | – | Sell |
-333
| Closed | -$44K | – | 593 |
|
|
2021
Q1 | $44K | Buy |
333
+118
| +55% | +$15.6K | ﹤0.01% | 1706 |
|
|
2020
Q4 | $28K | Hold |
215
| – | – | ﹤0.01% | 1598 |
|
|
2020
Q3 | $31K | Hold |
215
| – | – | ﹤0.01% | 1371 |
|
|
2020
Q2 | $32K | Sell |
215
-110
| -34% | -$16.4K | ﹤0.01% | 1310 |
|
|
2020
Q1 | $35K | Sell |
325
-198
| -38% | -$21.3K | ﹤0.01% | 1170 |
|
|
2019
Q4 | $60K | Buy |
523
+498
| +1,992% | +$57.1K | ﹤0.01% | 1092 |
|
|
2019
Q3 | $2K | Buy |
+25
| New | +$2K | ﹤0.01% | 2028 |
|